Form 4: Novanta Inc. General Counsel Michele Davis Welsh Reports Stock Transactions
SEC Form 4 Filing
Michele Davis Welsh, General Counsel of Novanta Inc., reports the vesting and disposal of restricted stock units on August 15, 2024.
Summary
- On August 15, 2024, Michele Davis Welsh, the General Counsel of Novanta Inc., executed transactions involving Novanta Inc. common stock.
- Welsh acquired 1,329 shares of common stock through the vesting of restricted stock units.
- Simultaneously, Welsh disposed of 590 shares to cover tax obligations at a price of $180.4 per share.
- Following these transactions, Welsh directly owns 1,478 shares of Novanta Inc. common stock and 1,330 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock transactions by an insider. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor management's perspective on the company's stock.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine transaction.
Key Dates
| Date | Description |
|---|---|
| 08/15/2023 | First vesting date of the Restricted Stock Units in three equal annual installments |
| 08/15/2024 | Date of transaction: vesting of restricted stock units and disposal of shares for tax obligations |
| 08/15/2025 | Final vesting date of the Restricted Stock Units in three equal annual installments |
| 08/19/2024 | Date of signature for the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.